Improving access to sickle cell care for children using telemedicine
Telemedicine for Pediatric Sickle Cell Care in Medically Underserved Communities
This study is looking at how using telemedicine can help kids with sickle cell disease in rural areas get better access to the care they need, making it easier for families to connect with doctors and improve their health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Indiana University Indianapolis NIH-funded |
| Lab location | 1 site (Indianapolis, United States) |
| Project ID | NIH-11075839 on NIH RePORTER |
What this research studies
This research investigates how telemedicine can enhance access to comprehensive care for children with sickle cell disease (SCD) living in rural and underserved communities. By utilizing modern technology, the project aims to overcome barriers to care that these families face, such as distance from specialized centers. The study will explore different telemedicine models to determine their effectiveness and acceptability in providing necessary medical services. The goal is to ensure that children with SCD receive timely and coordinated care, ultimately improving their health outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are children under 11 years old with sickle cell disease, particularly those living in rural or medically underserved areas.
Not a fit: Patients who do not have sickle cell disease or those living in well-served urban areas may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve access to quality healthcare for children with sickle cell disease, leading to better health outcomes and reduced complications.
How similar studies have performed: Previous studies have shown that telemedicine can be a safe and effective method for providing care, especially highlighted during the COVID-19 pandemic, indicating a promising approach for this research.
Where this research is happening
Indianapolis, United States
- Indiana University Indianapolis — Indianapolis, United States (Active)
Researchers
- Principal investigator: Jacob, Seethal — Indiana University Indianapolis
- Study coordinator: Jacob, Seethal
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.